XML 11 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash $ 137,497 $ 68,573
Accounts receivable, net 356,929 313,338
Prepaid expenses 12,249 18,159
Other current assets 3,158 3,030
Total current assets 509,833 403,100
Non-current assets    
Property and equipment 519,152 508,401
Intangible assets, net 805,457 894,952
Right of use assets 9,316,039 9,323,723
Deposits paid 409,000 389,000
Total non-current assets 11,049,648 11,116,076
Total assets 11,559,481 11,519,176
Current liabilities    
Accounts payable and accrued liabilities 336,401 352,101
Convertible notes, net of discounts 4,471,232 4,419,927
Short-term notes 1,037,617 680,672
Receivables funding 101,848 211,961
Government assistance loans 14,999 14,962
Operating lease liability 44,485 38,563
Finance lease liability 8,570 8,426
Related party payables 2,660,190 2,572,292
Total current liabilities 8,675,342 8,298,904
Non-current liabilities    
Government assistance loans 16,732 20,520
Operating lease liability 9,427,628 9,383,557
Finance lease liability 14,262 16,475
Total non-current liabilities 9,458,622 9,420,552
Total liabilities 18,133,964 17,719,456
Preferred stock - Series A; $0.01 par value, 10,000,000 authorized, 4,000,000 shares issued and outstanding as of March 31, 2024 and December 31, 2023 40,000 40,000
Common stock - $0.01 par value, 10,000,000,000 shares authorized; 3,729,053,805 and 3,729,053,805 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 37,290,539 37,290,539
Additional paid-in capital 26,187,925 26,187,925
Discount for shares issued below par value (27,363,367) (27,363,367)
Accumulated deficit (42,729,580) (42,355,377)
Total stockholders’ deficit (6,574,483) (6,200,280)
Total liabilities and stockholders’ deficit 11,559,481 11,519,176
Series B Preferred Stock [Member]    
Non-current liabilities    
Preferred stock - Series A; $0.01 par value, 10,000,000 authorized, 4,000,000 shares issued and outstanding as of March 31, 2024 and December 31, 2023